- Issuer ticker
-
UTHR
- Reported as of
-
24 Jul 2025
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
5 source fields
- SEC form
-
4
- Accepted by SEC
-
28 Jul 2025, 06:27:11 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ John S. Hess, Jr. under Power of Attorney
Key filing fact
Tommy G. Thompson filed Form 4 for UNITED THERAPEUTICS Corp (UTHR) on 28 Jul 2025.
Key facts
- This page summarizes Tommy G. Thompson's Form 4 filing for UNITED THERAPEUTICS Corp (UTHR).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 28 Jul 2025, 06:27.
Change
- Previous filing in this sequence was filed on 28 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001324863
Primary reporting owner
Thompson Tommy G
- Relationship
-
Director
- Address
- C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING
- Signature
- /s/ John S. Hess, Jr. under Power of Attorney
- Signature date
- 25 Jul 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
UTHR
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +3,650
- Change %
- Price
-
$0.000000
- Shares after
- 3,650
- Date
- 24 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,650
- Exercise price
- $306.41
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote